SIG SAUER Announces U.S. Army Designates Type Classification Milestone for the NGSW Lethality Program
NGSW Type Classified NEWINGTON, N.H., May 20, 2025 /PRNewswire/ -- SIG SAUER, industry…
ONLYFANS FOUNDER, TIM STOKELY, UNVEILS SUBS.COM: A NEW PLATFORM FOR ALL CREATORS
LONDON, May 8, 2025 /PRNewswire/ -- From the founder of OnlyFans, a…
Endogenex Highlights 48-Week REGENT-1 Clinical Study Results at Digestive Disease Week 2025
Novel Endoscopic Procedure Demonstrates Substantial and Durable Reduction in Insulin Resistance and…
China Application Security Market Opportunity Report 2025 | Driven by Emerging Tech such as AI and Cloud Security, the Market is Set to Expand to $23.66 Billion by 2029 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "China Application Security Market Opportunity and Future Growth Dynamics (Databook)…
KuCoin Achieves SOC 2 Type II Certification: Strengthening Security and Compliance Standards
VICTORIA, Seychelles, April 4, 2025 /PRNewswire/ -- KuCoin, a leading global cryptocurrency…
Novo Nordisk A/S: Rybelsus (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025
Rybelsus® reduced major adverse cardiovascular events by 14% vs placebo in adults…
Ozempic (once-weekly semaglutide 1.0 mg) shown to improve walking distance and quality of life in adults with type 2 diabetes and peripheral artery disease (PAD) at ACC 2025
Ozempic® improved maximum walking distance by 13% vs placebo in adults with…
VINSSEN Receives Type Approval for Maritime Fuel Cell Stack from RINA
SEOUL, South Korea, March 21, 2025 /PRNewswire/ -- VINSSEN, a maritime decarbonization…
vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
March 20, 2025 17:35 ET | Source: vTv Therapeutics Inc. Clinical hold…
Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five…